Drug profile · INN
mefenamic acid
FEMIN
mefenamic acid (FEMIN) is a cyclooxygenase inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — mefenamic acid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mefenamic acid (FEMIN) is a cyclooxygenase inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mefenamic acid?
mefenamic acid (FEMIN) is a cyclooxygenase inhibitor. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mefenamic acid?
FEMIN is a marketed brand name for mefenamic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mefenamic acid?
mefenamic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.